Evidence map›Paper›PMID 21375763›Full record

Trial reportBMC neurology2011

Migraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies.

Murugan K Ravindran, Yin Zheng, Christian Timbol, Samantha J Merck, James N Baraniuk

Open access · goldAbstract readClinical TrialComparative Study
In one paragraph

Trial report in BMC neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. The challenges of chronic pain and fatigue.Clinical medicine (London, England) · 2021
    Review
  11. Chronic fatigue syndrome in the emergency department.Open access emergency medicine : OAEM · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Worldwide epidemiology of fibromyalgia.Current pain and headache reports · 2013
    Review
  18. Cognitive impairment in fibromyalgia.Current pain and headache reports · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Murugan K RavindranDivision of Rheumatology, Immunology and Allergy, Georgetown University, 3800 Reservoir Road NW, Washington, DC 20007-2197, USA.
Yin Zheng
Christian Timbol
Samantha J Merck
James N Baraniuk
Georgetown University · US

Funding

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1RR031975 · NCRR · GEORGETOWN UNIVERSITY · PI VERBALIS, JOSEPH G · 2010 to 2011
$14.6M
Proteomics of Cerebrospinal Fluid in Chronic Fatigue SyndromeR01ES015382 · NIEHS · GEORGETOWN UNIVERSITY · PI BARANIUK, JAMES N · 2006 to 2009
$1.5M
NCRR NIH HHS 1UL1RR031975NIEHS NIH HHS R01 ES015382PHS HHS W81XWH-07-1-0618
6 · The paper itself

Abstract

backgroundHeadaches are more frequent in Chronic Fatigue Syndrome (CFS) than healthy control (HC) subjects. The 2004 International Headache Society (IHS) criteria were used to define CFS headache phenotypes.

methodsSubjects in Cohort 1 (HC = 368; CFS = 203) completed questionnaires about many diverse symptoms by giving nominal (yes/no) answers. Cohort 2 (HC = 21; CFS = 67) had more focused evaluations. They scored symptom severities on 0 to 4 anchored ordinal scales, and had structured headache evaluations. All subjects had history and physical examinations; assessments for exclusion criteria; questionnaires about CFS related symptoms (0 to 4 scale), Multidimensional Fatigue Inventory (MFI) and Medical Outcome Survey Short Form 36 (MOS SF-36).

resultsDemographics, trends for the number of diffuse "functional" symptoms present, and severity of CFS case designation criteria symptoms were equivalent between CFS subjects in Cohorts 1 and 2. HC had significantly fewer symptoms, lower MFI and higher SF-36 domain scores than CFS in both cohorts. Migraine headaches were found in 84%, and tension-type headaches in 81% of Cohort 2 CFS. This compared to 5% and 45%, respectively, in HC. The CFS group had migraine without aura (60%; MO; CFS+MO), with aura (24%; CFS+MA), tension headaches only (12%), or no headaches (4%). Co-morbid tension and migraine headaches were found in 67% of CFS. CFS+MA had higher severity scores than CFS+MO for the sum of scores for poor memory, dizziness, balance, and numbness ("Neuro-construct", p = 0.002) and perceived heart rhythm disturbances, palpitations and noncardiac chest pain ("Cardio-construct"; p = 0.045, t-tests after Bonferroni corrections). CFS+MO subjects had lower pressure-induced pain thresholds (2.36 kg [1.95-2.78; 95% C.I.] n = 40) and a higher prevalence of fibromyalgia (47%; 1990 criteria) compared to HC (5.23 kg [3.95-6.52] n = 20; and 0%, respectively). Sumatriptan was beneficial for 13 out of 14 newly diagnosed CFS migraine subjects.

conclusionsCFS subjects had higher prevalences of MO and MA than HC, suggesting that mechanisms of migraine pathogenesis such as central sensitization may contribute to CFS pathophysiology. CLINICAL

trial registrationGeorgetown University IRB # 2006-481

Indexed as

AdultComorbidityCross-Sectional StudiesFatigue Syndrome, ChronicFemaleFibromyalgiaHumansMaleMigraine DisordersPainPrevalenceProspective StudiesSelf ReportSeverity of Illness IndexSumatriptanTension-Type HeadacheSumatriptan

Identifiers

PMID21375763
PMCPMC3058027
OpenAlexW2107697308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.